<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://pharmadog.xyz/news/653843</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-08T09:30:00.000Z</news:publication_date>
      <news:title>Recent heart-drug trials miss endpoints, raising doubts about AI-driven drug design</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/651503</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-07T21:39:02.000Z</news:publication_date>
      <news:title>New studies highlight hurdles in lowering blood pressure after stroke or in diabetes patients</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/651459</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-07T21:12:08.000Z</news:publication_date>
      <news:title>FDA opens investigation into Novartis&apos; Zolgensma after cancer cases reported</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/650575</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-07T16:57:13.000Z</news:publication_date>
      <news:title>Biotech Trade Group BIO Sues Over Medicare GLOBE Pricing Pilot</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/650215</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-07T14:50:59.000Z</news:publication_date>
      <news:title>Novo and Novartis see heart drug setbacks as trials show minimal efficacy</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/650407</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-07T14:50:00.000Z</news:publication_date>
      <news:title>STAT+: Failure of Novartis Lp(a) drug raises questions about cardiovascular strategy</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/650408</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-07T14:35:00.000Z</news:publication_date>
      <news:title>Novo Nordisk’s anti-inflammatory drug ziltivekimab fails to cut heart events, but cardiologists still eye inflammation pathway</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/649603</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-07T11:00:46.000Z</news:publication_date>
      <news:title>Democrats Take House, Raising Questions for Biopharma Policy</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/647667</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-07T00:52:09.000Z</news:publication_date>
      <news:title>Harvard scientist George Church quits AI startup Radical, alleging partner stole his credit</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/647287</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-06T22:05:39.000Z</news:publication_date>
      <news:title>States sue Trump administration to halt Medicaid work-requirement rollout</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/647119</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-06T21:55:21.000Z</news:publication_date>
      <news:title>Former MAHA official Calley Means blames White House for yielding to industry pressure</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/647120</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-06T21:46:55.000Z</news:publication_date>
      <news:title>Newly elected scientists aim to restore health equity programs cut by Trump administration</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/646339</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-06T17:46:16.000Z</news:publication_date>
      <news:title>Democrats’ Midterm Win Promises Medicaid Reversal and ACA Subsidy Restoration for Hospitals</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/646340</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-06T17:02:18.000Z</news:publication_date>
      <news:title>Podcast examines Democrats&apos; midterm win and concerns over a costly, questionable fertility genetic procedure</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/646295</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-06T17:00:22.000Z</news:publication_date>
      <news:title>Immunocore reports early data showing 70% two-year survival with brenetafusp/Kimmtrak combo in uveal melanoma</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/646127</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-06T16:53:33.000Z</news:publication_date>
      <news:title>FDA grants accelerated approval to J&amp;J&apos;s Rybrevant for recurrent head and neck cancer</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/646359</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-06T16:51:00.000Z</news:publication_date>
      <news:title>Novartis reports nine cancer cases in patients treated with Zolgensma gene therapy</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/646171</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-06T16:43:49.000Z</news:publication_date>
      <news:title>MetaVia appoints Sarah Browne as chief medical officer</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/646151</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-06T16:43:26.000Z</news:publication_date>
      <news:title>Moderna reports 29% revenue rise as COVID vaccine sales stay steady amid global uptake</news:title>
    </news:news>
  </url>
</urlset>
